BfArM — authorised 15 September 2022
- Marketing authorisation holder: ELI LILLY NEDERLAND B.V.
- Status: approved
BfArM authorised Mounjaro on 15 September 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. BfArM authorised it on 15 September 2022.
ELI LILLY NEDERLAND B.V. holds the German marketing authorisation.